Skip to main content
logo
Prestige BioPharma Limited (KRX:950210)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,650
+390 (3.46%)
At close: Feb 6, 2026

Revenue by Product

Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024FY 2023FY 2019FY 2018
Period Ending
Jun '24 Jun '23 Jun '19 Jun '18
Anti-cancer Drugs
689.73M
Anti-cancer Drugs Growth
325.85%

Revenue by Geography

Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024FY 2023FY 2019FY 2018
Period Ending
Jun '24 Jun '23 Jun '19 Jun '18
Singapore
689.73M
Singapore Growth
325.85%